By Don Nico Forbes
Steris said the trial against its Isomedix subsidiary was dismissed and will be rescheduled for a later date.
The Irish medical-device company said the case, which began on Dec. 4, was declared a mistrial on Friday at the plaintiff's request after the dismissal of a juror reduced the jury to fewer than twelve.
The trial was set to address a claim that ethylene-oxide emissions from a sterilization facility in Waukegan, Illinois--which Isomedix owned and operated from 2005 to 2008--caused personal injury.
The Illinois court will schedule the case for retrial at a later date, the company said.
On Nov. 7, Steris disclosed that it was facing hundreds of lawsuits alleging harm arising from its use of ethylene oxide in the sterilization of medical devices.
"Isomedix intends to continue to vigorously defend against [the] allegations," it said.
Write to Don Nico Forbes at don.forbes@wsj.com
(END) Dow Jones Newswires
January 21, 2025 07:04 ET (12:04 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。